Deep Medicine (NASDAQ:DMAQ) announced this morning that it has terminated its $2.5 billion combination with Chinese carmaker Chijet.
Deep Medicine’s move comes after it made two amendments to the deal to extend the due diligence period. The first amendment was made on September 6, to extend Chijet’s due diligence period until September 20, in an effort to review the company’s operations and complete its own valuation of the Chinese carmaker. On September 16, the parties entered into the second amendment to extend the diligence expiration date until September 30. However, on September 26, Deep Medicine sent Chijet a termination notice.
The deal included a minimum cash condition of at least $10 million. Deep Medicine brought about $127.8 million from its current trust into the deal and did not supplement this with a PIPE.
Deep Medicine and Chijet mark the 45th deal to be terminated this year. The SPAC will not be obligated to pay any penalties pursuant to the terms of the business combination agreement as a result of the termination.
Deep Medicine initially announced its definitive agreement to combine with Chijet just a few months ago on July 13, 2022. Chijit currently sells a line of gasoline-fueled SUVs and trucks in China and Southeast Asia and is working to build a production facility for a new line of EVs.
At the SPAC of Dawn The faucet of new SPACs to market is fully open with two more new SPACs pricing overnight and Churchill X (NASDAQ:CCCXU) already fully over-allotted after its May 14 IPO. Of the two IPOs Wen Acquisition Corp (NASDAQ:WENNU) showed particular speed, having filed its initial S-1 just over two weeks ago...
Columbus Circle Capital Corp I (NASDAQ:CCCMU) announced the pricing of its upsized $220 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CCCMU”, Friday, May 16, 2025. The new SPAC aims to conduct a broad search for a target with a team that has expertise in telecoms, media,...
Wen Acquisition Corp (NASDAQ:WENNU) announced the pricing of its $261 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “WENNU”, Friday, May 16, 2025. The new SPAC aims to combine with a fintech target focused on enabling digital assets through the integration of blockchain networks into traditional financial...
Blue (NYSE:BACCU) has filed for a $150 million SPAC that will take a generalist search process, but it hopes to come down with an industrial target. The new SPAC is the 11th in a row to file without an offer to overfund its trust. It offers investors one right to a 1/10 share in each...
Axiom Intelligence Acquisition Corp. 1 (NYSE:AXINU) has filed for a $150 million SPAC that will look for opportunities among infrastructure targets in both the physical and digital spheres. The new SPAC is not overfunded and has one right to a 1/10 share in each unit with 24 months to initially complete a business combination. The...